Steven E. Aks

2.1k total citations
60 papers, 1.4k citations indexed

About

Steven E. Aks is a scholar working on Emergency Medicine, Public Health, Environmental and Occupational Health and Toxicology. According to data from OpenAlex, Steven E. Aks has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Emergency Medicine, 18 papers in Public Health, Environmental and Occupational Health and 12 papers in Toxicology. Recurrent topics in Steven E. Aks's work include Poisoning and overdose treatments (27 papers), Opioid Use Disorder Treatment (15 papers) and Forensic Toxicology and Drug Analysis (12 papers). Steven E. Aks is often cited by papers focused on Poisoning and overdose treatments (27 papers), Opioid Use Disorder Treatment (15 papers) and Forensic Toxicology and Drug Analysis (12 papers). Steven E. Aks collaborates with scholars based in United States, Israel and Canada. Steven E. Aks's co-authors include Sean M. Bryant, Yaron Finkelstein, Gideon Koren, Gal Dubnov‐Raz, Uri Pollak, Janine R. Hutson, David N. Juurlink, Yedidia Bentur, Patricia Nguyen and T. J. Neep and has published in prestigious journals such as Journal of General Internal Medicine, Drug and Alcohol Dependence and Annals of Emergency Medicine.

In The Last Decade

Steven E. Aks

60 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven E. Aks United States 19 390 270 244 241 163 60 1.4k
Janine R. Hutson Canada 17 191 0.5× 275 1.0× 140 0.6× 60 0.2× 146 0.9× 38 1.3k
Keith Burkhart United States 22 496 1.3× 187 0.7× 82 0.3× 110 0.5× 92 0.6× 66 1.4k
Tony W.L. Mak Hong Kong 25 110 0.3× 263 1.0× 137 0.6× 239 1.0× 137 0.8× 71 1.5k
Andrew R. Erdman United States 22 673 1.7× 99 0.4× 62 0.3× 100 0.4× 58 0.4× 23 1.2k
Catherine A. Hammett‐Stabler United States 18 106 0.3× 169 0.6× 411 1.7× 125 0.5× 49 0.3× 45 1.3k
A.R.W. Forrest United Kingdom 17 215 0.6× 94 0.3× 124 0.5× 422 1.8× 27 0.2× 43 1.1k
Jay L. Schauben United States 11 462 1.2× 85 0.3× 104 0.4× 101 0.4× 31 0.2× 24 962
G N Volans United Kingdom 22 538 1.4× 114 0.4× 111 0.5× 69 0.3× 54 0.3× 78 1.5k
Loralie J. Langman United States 27 60 0.2× 296 1.1× 199 0.8× 166 0.7× 45 0.3× 94 1.8k
Kenneth Kulig United States 24 1.1k 2.8× 170 0.6× 94 0.4× 102 0.4× 73 0.4× 49 2.3k

Countries citing papers authored by Steven E. Aks

Since Specialization
Citations

This map shows the geographic impact of Steven E. Aks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven E. Aks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven E. Aks more than expected).

Fields of papers citing papers by Steven E. Aks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven E. Aks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven E. Aks. The network helps show where Steven E. Aks may publish in the future.

Co-authorship network of co-authors of Steven E. Aks

This figure shows the co-authorship network connecting the top 25 collaborators of Steven E. Aks. A scholar is included among the top collaborators of Steven E. Aks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven E. Aks. Steven E. Aks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Devgun, Jason M., Theresa W. Kim, Mark B. Mycyk, et al.. (2019). An outbreak of severe coagulopathy from synthetic cannabinoids tainted with Long-Acting anticoagulant rodenticides. Clinical Toxicology. 58(8). 821–828. 18 indexed citations
2.
Navon, Livia, Erin D. Moritz, Connie Austin, et al.. (2019). The Public Health Response to a Large Poisoning Outbreak Involving an Illicit Substance: Synthetic Cannabinoids Contaminated With a Long-Acting Anticoagulant Rodenticide, Illinois, March-July, 2018. Journal of Public Health Management and Practice. 26(6). E1–E7. 7 indexed citations
3.
Doyon, Suzanne, et al.. (2014). Expanding Access to Naloxone in the United States. Journal of Medical Toxicology. 10(4). 431–434. 32 indexed citations
4.
Doyon, Suzanne, et al.. (2014). Expanding access to naloxone in the United States. Clinical Toxicology. 52(10). 989–992. 31 indexed citations
5.
Finkelstein, Yaron, Steven E. Aks, Janine R. Hutson, et al.. (2010). Colchicine poisoning: the dark side of an ancient drug. Clinical Toxicology. 48(5). 407–414. 423 indexed citations
6.
Aks, Steven E., et al.. (2010). Case Files of the Toxikon Consortium in Chicago: Survival after Intentional Ingestion of Hydrofluoric Acid. Journal of Medical Toxicology. 6(3). 349–354. 9 indexed citations
7.
Mottram, Allan R., Sean M. Bryant, & Steven E. Aks. (2010). Effect of Cyclodextrin Infusion in a Rat Model of Verapamil Toxicity. American Journal of Therapeutics. 18(5). 371–374. 7 indexed citations
8.
Bryant, Sean M., et al.. (2009). Parenteral Ophthalmic Tropicamide or Cyclopentolate Protects Rats From Lethal Organophosphate Poisoning. American Journal of Therapeutics. 16(3). 231–234. 4 indexed citations
9.
Wills, Brandon K., et al.. (2009). Bupropion-Associated QRS Prolongation Unresponsive to Sodium Bicarbonate Therapy. American Journal of Therapeutics. 16(2). 193–196. 14 indexed citations
10.
Thompson, Trevonne M. & Steven E. Aks. (2007). Case files of the Toxikon Medical Toxicology Fellowship in Chicago: The poisoned anesthesiologist. Journal of Medical Toxicology. 3(1). 31–36. 3 indexed citations
11.
Bryant, Sean M., et al.. (2006). Intramuscular ophthalmic homatropine vs. atropine to prevent lethality in rates with dichlorvos poisoning. Journal of Medical Toxicology. 2(4). 156–159. 5 indexed citations
12.
Mycyk, Mark B., et al.. (2003). Nebulized Naloxone gently and effectively reverses methadone intoxication. Journal of Emergency Medicine. 24(2). 185–187. 14 indexed citations
13.
Aks, Steven E., et al.. (1999). False-negative abdominal CT scan in a cocaine body stuffer. The American Journal of Emergency Medicine. 17(7). 702–704. 32 indexed citations
14.
Leikin, Jerrold B., Steven E. Aks, Steven Andrews, et al.. (1997). Foreword. Disease-a-Month. 43(12). 813–916. 7 indexed citations
15.
Erickson, Timothy B., et al.. (1996). Acute Renal Toxicity After Ingestion of Lava Light Liquid. Annals of Emergency Medicine. 27(6). 781–784. 8 indexed citations
16.
Aks, Steven E., et al.. (1996). Late Increase in Acetaminophen Concentration After Overdose of Tylenol Extended Relief. Annals of Emergency Medicine. 28(5). 549–551. 32 indexed citations
17.
Aks, Steven E., et al.. (1995). Fractional Mercury Levels in Brazilian Gold Refiners and Miners. Journal of Toxicology Clinical Toxicology. 33(1). 1–10. 23 indexed citations
18.
Leikin, Jerrold B., et al.. (1994). The toxic patient as a potential organ donor. The American Journal of Emergency Medicine. 12(2). 151–154. 32 indexed citations
19.
Branches, Fernando J.P., Timothy B. Erickson, Steven E. Aks, & Daniel Hryhorczuk. (1993). The Price of Gold: Mercury Exposure in the Amazonian Rain Forest. Journal of Toxicology Clinical Toxicology. 31(2). 295–306. 56 indexed citations
20.
Hoek, Terry L. Vanden, Caroline Murphy, Steven E. Aks, & Frank P. Paloucek. (1991). The use of esmolol to reverse unstable supraventricular tachycardia in a theophylline toxic patient. 33(4). 390. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026